Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Expression data from human non-alcoholic fatty liver disease stages


ABSTRACT: Global gene expression patterns of 2 human steatosis and 9 human non-alcoholic steatohepatitis (NASH) together with their respective control patterns were analyzed to define the non-alcoholic fatty liver disease (NAFLD) progression molecular characteristics and to define NASH early markers from steatosis. Human liver samples of steatosis and non-alcoholic steatohepatitis were selected for RNA extraction and hybridization on Affymetrix microarrays. This dataset is part of the TransQST collection.

ORGANISM(S): Homo sapiens

SUBMITTER: Itziar Frades 

PROVIDER: E-GEOD-63067 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Integrative genomic signatures of hepatocellular carcinoma derived from nonalcoholic Fatty liver disease.

Frades Itziar I   Andreasson Erik E   Mato Jose Maria JM   Alexandersson Erik E   Matthiesen Rune R   Martínez-Chantar Maria Luz ML  

PloS one 20150520 5


Nonalcoholic fatty liver disease (NAFLD) is a risk factor for Hepatocellular carcinoma (HCC), but he transition from NAFLD to HCC is poorly understood. Feature selection algorithms in human and genetically modified mice NAFLD and HCC microarray data were applied to generate signatures of NAFLD progression and HCC differential survival. These signatures were used to study the pathogenesis of NAFLD derived HCC and explore which subtypes of cancers that can be investigated using mouse models. Our f  ...[more]

Similar Datasets

2014-11-07 | GSE63067 | GEO
2022-05-09 | E-MTAB-11688 | biostudies-arrayexpress
2016-01-01 | GSE69670 | GEO
2013-04-02 | E-GEOD-37031 | biostudies-arrayexpress
2015-01-23 | E-GEOD-65220 | biostudies-arrayexpress
2014-11-07 | GSE63027 | GEO
2011-07-12 | E-MEXP-3291 | biostudies-arrayexpress
2024-11-18 | GSE277545 | GEO
2022-03-24 | PXD032806 |
2016-06-22 | E-GEOD-83596 | biostudies-arrayexpress